Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Management tracks: Verastem CEO Forrester steps down; plus Recursion, N8 Medical

Verastem Inc. (NASDAQ:VSTM) said Robert Forrester will step down as president and CEO.

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE